Thứ tư, 05/05/2021 09:10 GMT+7

Các nghiên cứu mới nhất về Covid-19 trong tháng 4 năm 2021

Trước tình hình dịch bệnh viêm đường hô hấp cấp do chủng mới của virus corona (COVID-19) gây ra, cuộc chiến đấu chống lại dịch bệnh đang được lan tỏa rộng rãi trong cộng đồng khoa học quốc tế. Trong tháng 4 năm 2021, có 180 bài nghiên cứu được đăng hoặc chấp nhận đăng trên các tạp chí khoa học quốc tế chính thống của các nhà xuất bản Elsevier, Springer Nature, Weley, Pubmed. Các nhà xuất bản đều công khai những bài viết này, ngay cả khi chưa được xuất bản chính thức.

Để tạo thuận lợi cho công tác nghiên cứu, điều trị và phòng chống dịch viêm đường hô hấp cấp do COVID-19, Cục Thông tin khoa học và công nghệ quốc gia tập hợp danh sách các công bố quốc tế mới nhất về nội dung này (có file toàn văn tại đường link kèm theo) để các bác sĩ, nhân viên y tế và các nhà nghiên cứu của Việt Nam tiện theo dõi. Danh sách sẽ được cập nhật thường xuyên theo tiến độ xuất bản điện tử.




1. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge            

International Immunopharmacology, 12 March 2021, Volume 95 (Cover date: June 2021), Article 107579

Lu-Xiao Hong, Lian Liu, Wei-Hua Yan


2. Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients

International Journal of Infectious Diseases, 20 January 2021, Volume 104 (Cover date: March 2021), Pages 661-669

C. Serre-Miranda, C. Nobrega, M. Correia-Neves


3. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Cell Reports Medicine, 26 January 2021, Volume 2, Issue 2 (Cover date: 16 February 2021), Article 100204

Alison Tarke, John Sidney, Alessandro Sette


4. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity

iScience, 9 January 2021, Volume 24, Issue 2 (Cover date: 19 February 2021), Article 102052

Monique Bennett, Sandra Yoder, Isaac Thomsen


5. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience

Clinical Biochemistry, 30 January 2021, Volume 90 (Cover date: April 2021), Pages 8-14

Laura De Michieli, Luciano Babuin, Allan S. Jaffe


6. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications

Journal of Theoretical Biology, 26 January 2021, Volume 515 (Cover date: 21 April 2021), Article 110604

Changchuan Yin


7. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro

Heliyon, 11 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06426

Omonike A. Olaleye, Manvir Kaur, Tolulope Adebusuyi


8. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?

Journal of Virological Methods, 13 January 2021, Volume 290 (Cover date: April 2021), Article 114064

Tania Regina Tozetto-Mendoza, Kelly Aparecida Kanunfre, Maria Cassia Mendes-Correa


9. Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2

Gene Reports, 1 March 2021, Volume 23 (Cover date: June 2021), Article 101064

Zaid Almubaid, Hisham Al-Mubaid


10. A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

Virus Research, 19 January 2021,Volume 295 (Cover date: 2 April 2021), Article 198305

Sylvie Roy, Karim Ghani, Manuel Caruso


11. Severe acute respiratory syndrome coronavirus 2 infection in asymptomatic pediatric dental patients

The Journal of the American Dental Association, 19 January 2021, Volume 152, Issue 4 (Cover date: April 2021), Pages 277-283

Flavia Lamberghini, Gabriela Trifan, Fernando D. Testai


12. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein

Heliyon, 19 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06564

Shweta Alai, Nidhi Gujar, Sunil Gairola


13. The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates

Heliyon, 1 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06167

Gajendra Kumar Azad


14. In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)

Informatics in Medicine Unlocked, 12 January 2021, Volume 23 (Cover date: 2021), Article 100516

Elham Aghaee, Marzieh Ghodrati, Jahan B. Ghasemi


15. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available

Clinica Chimica Acta, 17 March 2021, Volume 518 (Cover date: July 2021), Pages 9-16

Thomas Mueller


16. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms

Molecular Cell, 1 January 2021, Volume 81, Issue 3 (Cover date: 4 February 2021), Pages 584-598.e5

Nicholas C. Huston, Han Wan, Anna Marie Pyle


17. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens

International Journal of Infectious Diseases, 25 February 2021, Volume 105 (Cover date: April 2021), Pages 617-620

Vijay Singh, Pallavi Upadhyay, John Granger


18. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors

Heliyon, 27 February 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06395

Sayantan Laha, Chinmay Saha, Nitai P. Bhattacharyya


19. COVID-19 patients may become predisposed to pulmonary arterial hypertension

Medical Hypotheses, 6 January 2021, Volume 147 (Cover date: February 2021), Article 110483

Yuichiro J. Suzuki, Sofia I. Nikolaienko, Sergiy G. Gychka


20. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19                     

Chemical Engineering Journal, 19 March 2021, Volume 418 (Cover date: 15 August 2021), Article 129392

Bin Zheng, Wenchang Peng, Dong Ming


21. Exploring existing drugs: proposing potential compounds in the treatment of COVID-19

Heliyon, 25 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06284

Eva Rahman Kabir, Nashrah Mustafa, Easin Uddin Syed


22. SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection

Biochemistry and Biophysics Reports, 3 February 2021, Volume 26 (Cover date: July 2021), Article 100938

Iman Hassan Ibrahim, Doha El-Sayed Ellakwa


23. Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties

Heliyon, 26 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06603

Ayoub Khaldan, Soukaina Bouamrane, Tahar Lakhlifi


24. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay

International Journal of Infectious Diseases, 12 February 2021, Volume 105 (Cover date: April 2021), Pages 21-25

Gustavo Echeverría, Ángel Guevara, Jacobus H. de Waard


25. Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach

Inorganica Chimica Acta, 11 February 2021, Volume 519 (Cover date: 1 May 2021), Article 120287

Thomas Scior, Hassan H. Abdallah, Dieter Rehder


26. Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2

Journal of King Saud University - Science, 4 February 2021, Volume 33, Issue 2 (Cover date: March 2021), Article 101352

Mebarka Ouassaf, Salah Belaidi, Thet Thet Htar


27. Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection

Biosensors and Bioelectronics, 16 March 2021, Volume 183 (Cover date: 1 July 2021), Article 113165

Richard B. M. Schasfoort, Jos van Weperen, A. H. Leontine Mulder


28. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers

Journal of Infection, 13 February 2021, Volume 82, Issue 3 (Cover date: March 2021), Pages 399-406

Letícia Adrielle dos Santos, Pedro Germano de Góis Filho, Roque Pacheco de Almeida


29. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19

Phytomedicine Plus, 18 March 2021, Volume 1, Issue 4 (Cover date: November 2021), Article 100058

Jin A. Shin, Subin Oh, Jong-Moon Jeong


30. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus                       

Carbohydrate Polymers, 14 February 2021, Volume 260 (Cover date: 15 May 2021), Article 117797

Lufeng Yan, Yuefan Song, Robert J. Linhardt


31. Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays

EBioMedicine, 12 February 2021, Volume 64 (Cover date: February 2021), Article 103236

Nuttada Panpradist, Qin Wang, Barry R. Lutz


32. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

Heliyon, 8 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e05990

M. F. Nagoor Meeran, Hayate Javed, Shreesh Ojha


33. SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection

Diagnostic Microbiology and Infectious Disease, 9 February 2021, Volume 100, Issue 2 (Cover date: June 2021), Article 115338

Saurabh Gombar, Timothy Bergquist, Niaz Banaei


34. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy

Atherosclerosis, 15 February 2021, Volume 322 (Cover date: April 2021), Pages 39-50

Thiago Quinaglia, Mahsima Shabani, Andrei C. Sposito


35. In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach

European Journal of Pharmaceutical Sciences, 19 February 2021, Volume 160 (Cover date: 1 May 2021), Article 105771

Yiming Zhang, Rory A Greer,Yuhua Song


36. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Cell, 9 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1858-1864.e10

Elizabeth M. Anderson, Eileen C. Goodwin, Scott E. Hensley



37. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro

Biochemical and Biophysical Research Communications, 10 February 2021, Volume 547 (Cover date: 2 April 2021), Pages 23-28

Minsu Jang, Rackhyun Park, Junsoo Park



38. Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019

Cytokine, 19 March 2021, Volume 142 (Cover date: June 2021), Article 155500

Guo-Lin Wang, Hui-Xia Gao, Xiang-Na Zhao



39. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development

Pharmacological Research, 26 March 2021, Volume 168 (Cover date: June 2021), Article 105581

Vincenzo Lionetti, Sveva Bollini, Tommaso Angelone



40. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages

Heliyon, 2 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06187

Ken Shirato, Takako Kizaki



41. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders

Cytokine & Growth Factor Reviews, 19 February 2021, Volume 58 (Cover date: April 2021), Pages 1-15

Narayanappa Amruta, Wesley H. Chastain, Gregory Bix



42. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors

Cytokine & Growth Factor Reviews, 9 February 2021, Volume 58 (Cover date: April 2021), Pages 55-65

Jorge Quarleri, M. Victoria Delpino



43. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019               

Clinica Chimica Acta, 22 February 2021, Volume 517 (Cover date: June 2021), Pages 48-53

Ding-Hui Peng, Yi Luo, Wei Chen



44. Combined recombinase polymerase amplification/rkDNA–graphene oxide probing system for detection of SARS-CoV-2

Analytica Chimica Acta, 19 March 2021, Volume 1158 (Cover date: 8 May 2021), Article 338390

Moon Hyeok Choi, Jaehyeon Lee, Young Jun Seo



45. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

Journal of Molecular Structure, 26 March 2021, Volume 1237 (Cover date: 5 August 2021), Article 130366

Kalyan Ghosh, Sk. Abdul Amin, Tarun Jha



46. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome

Journal of Allergy and Clinical Immunology, 9 February 2021, Volume 147, Issue 4 (Cover date: April 2021), Pages 1226-1233.e2

Christian Rosas-Salazar, Kyle S. Kimura, Suman R. Das



47. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19

Heliyon, 28 January 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06133

Fahd Al-Mulla, Anwar Mohammad, Thangavel Alphonse Thanaraj


48. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Biochimica et Biophysica Acta (BBA) - General Subjects, 14 March 2021, Volume 1865, Issue 6 (Cover date: June 2021), Article 129893

Wen-Hsiang Chen, Junfei Wei, Maria Elena Bottazzi



49. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

iScience, 9 March 2021, Volume 24, Issue 4 (Cover date: 23 April 2021), Article 102293

Xiaoyuan Lin, Beibei Fu, Haibo Wu


50. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection

Journal of Lipid Research, 2 March 2021, Volume 62 (Cover date: 2021), Article 100061

James R. Hilser, Yi Han, Hooman Allayee


51. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis

International Journal of Infectious Diseases, 11 February 2021, Volume 105 (Cover date: April 2021), Pages 351-356

Januar Wibawa Martha, Raymond Pranata, Michael Anthonius Lim



52. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis

Chemico-Biological Interactions, 18 February 2021, Volume 338 (Cover date: 1 April 2021), Article 109420

Yajing Hou, Shuai Ge, Langchong He



53. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.

EBioMedicine, 2 April 2021, Volume 66 (Cover date: April 2021), Article 103317

Aishwarya Venkataraman, Nathella Pavan Kumar, Subash Babu



54. The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review

Heart & Lung, 27 February 2021, Volume 50, Issue 4 (Cover date: July–August 2021),Pages 481-490

Woon H. Chong, Biplab K. Saha, Amit Chopra



55. Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series

Multiple Sclerosis and Related Disorders, 13 March 2021, Volume 51 (Cover date: June 2021), Article 102900

Nurhan Kaya Tutar, Sami Omerhoca, Nilufer Kale



56. Forensic evaluation of two nucleic acid extraction systems and validation of a RT-qPCR protocol for identification of SARS-CoV-2 in post-mortem nasopharyngeal swabs

Forensic Science International, 2 April 2021m Volume 323 (Cover date: June 2021)m Article 110775

Pedro A. Barrio, Amparo Fernández-Rodríguez, Antonio Alonso



57. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

Virology, 5 March 2021, Volume 558 (Cover date: June 2021), Pages 13-21

Kaustuv Nayak, Kamalvishnu Gottimukkala, Anmol Chandele



58. A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19

Journal of Infection and Chemotherapy, 19 February 2021, Volume 27, Issue 6 (Cover date: June 2021), Pages 876-881

Wei-Jing Gong, Tao Zhou, Xue-Feng Cai


59. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Cell, 2 February 2021, Volume 184, Issue 5 (Cover date: 4 March 2021), Pages 1201-1213.e14

Aurélien Sokal, Pascal Chappert, Matthieu Mahévas



60. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

International Journal of Biological Macromolecules, 4 February 2021, Volume 176 (Cover date: 15 April 2021), Pages 1-12

Ashuai Du, Rong Zheng, Zanxian Xia



61. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients

Cell Reports, 12 March 2021, Volume 34, Issue 13 (Cover date: 30 March 2021), Article 108915

Yang Li, Ming-liang Ma, Sheng-ce Tao



62. Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment

Biomedicine & Pharmacotherapy, 8 April 2021, Volume 139 (Cover date: July 2021), Article 111586

Jing Qian, Hangdi Xu, Xiaohui Fan



63. Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?

Medical Hypotheses, 25 March 2021, Volume 151 (Cover date: June 2021), Article 110570

Selma Rivas-Fuentes, Víctor Julián Valdés, Alfonso Salgado-Aguayo



64. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2                   

International Journal of Biological Macromolecules, 16 April 2021, Volume 181 (Cover date: 30 June 2021), Pages 801-809

Sk. Sarif Hassan, Diksha Attrish, Adam M. Brufsky



65. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues

International Immunopharmacology, 10 March 2021, Volume 95 (Cover date: June 2021), Article 107567

Bingfeng Zheng, Manman Yuan, Qiang Xu



66. Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation

Heliyon, 5 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06435

Md. Kamrul Hasan, Mohammad Kamruzzaman, Atiqur Rahman



67. Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy

International Journal of Infectious Diseases, 2 February 2021, Volume 104 (Cover date: March 2021), Pages 696-700

Moris Sangineto, Fabio Arena, Gaetano Serviddio



68. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs

Cell, 9 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1865-1883.e20

Lei Sun, Pan Li, Qiangfeng Cliff Zhang



69. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes

iScience, 12 February 2021, Volume 24, Issue 3 (Cover date: 19 March 2021), Article 102187

Ziliang Zhou, Chunliu Huang, Shoudeng Chen



70. Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19

International Journal of Infectious Diseases, 27 February 2021, Volume 105 (Cover date: April 2021), Pages 463-469

Cyrine Bennasrallah, Imen Zemni, Asma Sriha Belguith



71. Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2

Journal of Virological Methods, 8 April 2021, Volume 293 (Cover date: July 2021), Article 114151

Kanti Pabbaraju, Anita A. Wong, Graham A. Tipples



72. Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

Biomedicine & Pharmacotherapy, 25 February 2021, Volume 138 (Cover date: June 2021), Article 111437

Justin Fortune Creeden, Ali Sajid Imami, Cheryl B. McCullumsmith



73. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm

Nano Today, 8 April 2021, Volume 38 (Cover date: June 2021), Article 101149

Hyelim Kim, Han Sol Lee, Wonhwa Lee



74. Relationship between blood eosinophil levels and COVID-19 mortality

World Allergy Organization Journal, 11 February 2021, Volume 14, Issue 3 (Cover date: March 2021), Article 100521

Bingdi Yan, Junling Yang, Xiaolei Tang



75. Factors associated with viral clearance periods from patients with COVID-19: A retrospective observational cohort study

Journal of Infection and Chemotherapy, 18 February 2021, Volume 27, Issue 6 (Cover date: June 2021), Pages 864-868

Nobuyasu Hirai, Yuichi Nishioka, Kei Kasahara


76. Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

Journal of Biological Chemistry, 25 February 2021, Volume 296 (Cover date: 2021), Article 100470

Einat B. Vitner, Hagit Achdout, Tomer Israely



77. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Cell, 23 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1821-1835.e16

Emanuele Andreano, Emanuele Nicastri, Rino Rappuoli



78. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines

Virology, 22 February 2021, Volume 558 (Cover date: June 2021), Pages 1-12

Ahmed S. Abdel-Moneim, Elsayed M. Abdelwhab, Ziad A. Memish



79. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes

European Journal of Pharmacology, 3 February 2021, Volume 896 (Cover date: 5 April 2021), Article 173930

Mohammad A. I. Al-Hatamleh, Ma'mon M. Hatmal, Rohimah Mohamud



80. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

Med, 10 February 2021, Volume 2, Issue 3 (Cover date: 12 March 2021), Pages 281-295.e4

Natalia Sherina, Antonio Piralla, Qiang Pan-Hammarström



81. Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing

Journal of Hospital Infection, 8 February 2021, Volume 110 (Cover date: April 2021), Pages 178-183

S. Paltansing, R. S. Sikkema, P. de Man


82. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR

International Journal of Infectious Diseases, 5 February 2021, Volume 105 (Cover date: April 2021), Pages 7-14

Yosuke Hirotsu, Makoto Maejima, Masao Omata



83. Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry

Journal of Colloid and Interface Science, 10 March 2021, Volume 594 (Cover date: 15 July 2021), Pages 195-203

Ieva Plikusiene, Vincentas Maciulis, Arunas Ramanavicius







1. Factors associated with SARS‐CoV‐2 infection in patients attending an acute hospital ambulatory assessment unit

G Ronan, L Kumar M Davey, C O'Leary, S McAleer, J Lynch R Lavery, J Campion, J Ryan, PJ O'Donoghue A Daly, J Shanahan, S Costelloe, C Sadlier, C McGlade, S Manning, J Carroll, S O'Flynn, P Barry, J Chevarria

Journal of Medical Virology

First published: 26 March 2021



2. COVID‐19 with and without anosmia or dysgeusia: A case‐control study

Nishanth Dev, Jhuma Sankar, Nitesh Gupta, Ramesh Chand Meena, Charanjit Singh, D. K. Gupta, M. K. Sen

Journal of Medical Virology,Volume 93, Issue 4

First published: 08 January 2021



3. Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients

Jie Cheng, Xiang Zhou, Weijun Feng, Min Jia, Xinlu Zhang, Taixue An, Minyuan Luan, Yi Pan, Shu Zhang, Zhaoming Zhou, Lei Wen, Yun Sun, Cheng Zhou

Journal of Cellular and Molecular Medicine

First published: 23 March 2021



4. Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data

Abbas Khan, Tauqir Zia, Muhammad Suleman, Taimoor Khan, Syed Shujait Ali, Aamir Ali Abbasi, Anwar Mohammad, Dong‐Qing Wei

Journal of Cellular Physiology

First published: 23 March 2021



5. Use of Chlorhexidine to Eradicate Oropharyngeal SARS‐CoV‐2 in COVID‐19 Patients

Y. Hanna Huang B.A., Jong T. Huang M.D.

Journal of Medical Virology

First published: 23 March 2021



6. SARS‐CoV‐2‐specific serological and functional T‐cell Immune responses during acute and early COVID‐19 convalescence in Solid Organ Transplant patients

Alexandre Favà, Laura Donadeu, Nuria Sabé, Vincent Pernin, José Gonzalez ‐ Costello, Laura Lladó, Maria Meneghini, Elena Garcia ‐ Romero, Alba Cachero, Alba Torija, Ronny Rodriguez ‐ Urquia, Elena Crespo, Iris Teubel, Edoardo Melilli, Nuria Montero, Anna Manonelles, Rosemarie Preyer, Kevin Strecker, Anne Ovize, Juan J Lozano, Julia Sidorova, Josep M Cruzado, Moglie Le Quintrec, Olivier Thaunat, Oriol Bestard

American Journal of Transplantation

First published: 23 March 2021


7. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis

Anupam Kumar Singh, Anuraag Jena, Praveen Kumar‐M, Vishal Sharma, Shaji Sebastian

United European Gastroenterology Journal

First published: 23 March 2021



8. Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages

Antonio Recchiuti, Sara Patruno, Domenico Mattoscio, Elisa Isopi, Antonella Pomilio, Alessia Lamolinara, Manuela Iezzi, Romina Pecce, Mario Romano

The FASEB Journal

First published: 22 March 2021



9. Quantitative pleural line characterization outperforms traditional lung texture ultrasound features in detection of COVID‐19

Laith R. Sultan MD, MPH, Yale Tung Chen MD Theodore W. Cary MS, Khalid Ashi MD, Chandra M. Sehgal PhD

Journal of the American College of Emergency Physicians Open

First published: 02 April 2021



10. Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications

Tosti J. Mankelow, Belinda K. Singleton, Pedro L. Moura, Christian J. Stevens‐Hernandez, Nicola M. Cogan, Gyongyver Gyorffy, Sabine Kupzig, Luned Nichols, Claire Asby, Jennifer Pooley, Gabriella Ruffino, Faroakh Hosseini, Fiona Moghaddas, Marie Attwood, Alan Noel, Alex Cooper, David T. Arnold, Fergus Hamilton, Catherine Hyams, Adam Finn , Ashley M. Toye, David J. Anstee


First published: 02 April 2021


11. Relationship between viral load, infection‐to‐delivery interval and mother‐to‐child transfer of anti‐SARS‐CoV‐2 antibodies

L. C. Poon, B. W. Leung T. Ma, F. N. Yu C. W. Kong, T. K. Lo, P. L. So, W. C. Leung, W. Shu, K. W. Cheung, S. Moungmaithong, C. C. Wang

Ultrasound in Obstetrics & Gynecology

First published: 02 April 2021



12. Detectable respiratory SARS‐CoV‐2 RNA is associated with low vitamin D levels and high social deprivation

Mark Livingston, Aiden Plant, Simon Dunmore, Andrew Hartland, Stephen Jones, Ian Laing, Sudarshan Ramachandran

International Journal of Clinical Practice

First published: 02 April 2021



13. Discovery of Potent Covid‐19 Main Protease Inhibitors using Integrated Drug Repurposing Strategy

T. Muthu Kumar, K. Rohini, Nivya James, V. Shanthi, K. Ramanathan

Biotechnology and Applied Biochemistry

First published: 01 April 2021



14. Ultrasound and Doppler findings in pregnant SARS‐CoV‐2 positive women

E. Soto‐Torres, E. Hernandez Andrade, E. Huntley, H. Mendez‐Figueroa, S. C. Blackwell

Ultrasound in Obstetrics & Gynecology

First published: 01 April 2021



15. The ROX index can be a useful tool for the triage evaluation of COVID‐19 patients with dyspnoea

Arian Zaboli, Dietmar Ausserhofer, Norbert Pfeifer, Serena Sibilio, Giovanna Tezza, Laura Ciccariello, Gianni Turcato

Journal of Advanced Nursing

First published: 01 April 2021



16. Effect of corticosteroids on mortality in hospitalized COVID‐19 patients not receiving invasive mechanical ventilation

Federica Fusina, Filippo Albani, Enza Granato, Angelo Meloni, Renzo Rozzini, Tony Sabatini, Roberto Stellini , Paolo Terragnoli, Antonio Rosano, Mohammed Abu Hilal, Giuseppe Natalini

Clinical Pharmacology & Therapeutics

First published: 31 March 2021



17. Increased B Cell activity with consumption of activated monocytes in severe COVID‐19 patients

Igor Kos, Benedikt Balensiefer, Vadim Lesan, Dominic Kaddu‐Mulindwa, Lorenz Thurner, Konstantin Christofyllakis, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Martina Seiffert, Stefan Wagenpfeil, Yvonne Bewarder, Frank Neumann, Torben Rixecker, Sigrun Smola, Andreas Link, Marcin Krawczyk, Frank Lammert, Philipp M. Lepper, Robert Bals, Stephan Stilgenbauer, Moritz Bewarder

European Journal of Immunology

First published: 31 March 2021



18. Field evaluation of COVID‐19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity and low cost

Elaine M Matsuda, Ivana Barros de Campos, Isabela Penteriche de Oliveira, Daniela Rodrigues Colpas Andreia Moreira dos Santos Carmo, Luís Fernando de Macedo Brígido

Journal of Medical Virology

First published: 31 March 2021

19. Short‐term impact of nursing home SARS‐CoV‐2 vaccinations on new infections, hospitalizations, and deaths

Vincent Mor PhD, Roee Gutman PhD, Xiaofei Yang ScM, Elizabeth M. White APRN, PhD Kevin W. McConeghy PharmD, MS Richard A. Feifer MD, MPH Carolyn R. Blackman MD Cyrus M. Kosar MS Barbara H. Bardenheier PhD Stefan A. Gravenstein MD, MPH

Journal of the American Geriatrics Society

First published: 16 April 2021



20. Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS‐CoV‐2

Alaa Shaheen


First published: 15 April 2021



21. Impact of cancer history on outcomes among hospitalized COVID‐19 patients

Isaac A. Klein MD, PhD Shoshana M. Rosenberg ScD, MPH Kerry L. Reynolds MD Leyre Zubiri MD, PhD Rachel Rosovsky MD Andrew J. Piper‐Vallillo MD Xin Gao MD Genevieve Boland MD, PhD Aditya Bardia MBBS, MPH Rachel Gaither BS Hannah Freeman BA Gregory J. Kirkner MPH Chanu Rhee MD, MPH Michael Klompas MD Meghan A. Baker MD, ScD Martha Wadleigh MD Eric P. Winer MD Camille N. Kotton MD Ann H. Partridge MD, MPH

The Oncologist

First published: 15 April 2021



22. Diabetic ketoacidosis drives COVID‐19 related hospitalizations in children with type 1 diabetes

G. Todd Alonso, Osagie Ebekozien, Mary Pat Gallagher, Saketh Rompicherla, Sarah K. Lyons Abha Choudhary, Shideh Majidi, Catherina T. Pinnaro, Sadana Balachandar, Mariam Gangat, Alissa Jeanne Curda ,Roberts Brynn E. Marks, Ana Creo, Janine Sanchez, Tossaporn Seeherunvong, Jose Jimenez‐Vega, Neha S. Patel, Jamie R. Wood Liana Gabriel, Kathryn M. Sumpte,r Meredith Wilkes, Robert Rapaport, Anna Cymbaluk ,Jenise C. Wong, Srinath Sanda, Anastasia Albanese‐O'neill

Journal of Diabetes

First published: 14 April 2021



23. Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit

Chiara Novelli, Erika Borotto, Ivo Beverina, Veronica Punzi, Danilo Radrizzani, Bruno Brando

International Journal of Laboratory Hematology

First published: 14 April 2021



24. Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics

Enrico Capuzzi, Alice Caldiroli, Silvia Leo, Massimiliano Buoli, Massimo Clerici

Human Psychopharmacology: Clinical and Experimental

First published: 14 April 2021




25. Comparison of saliva with oral and nasopharyngeal swabs for SARS‐CoV‐2 detection on various commercial and laboratory developed assays

Annie‐Claude Labbé MD, Patrick Benoit MD, Sarah Gobeille Paré MD, François Coutlée MD, Simon Lévesque PhD, Mcb.A., RMCCM Julie Bestman‐Smith MD, PhD, Jeannot Dumaresq MD, Christian Lavallée MD, Claudia Houle MD, Philippe Martin MD, Anton Mak MD, Philippe Gervais MD, Stéphanie Langevin MD, Mariève Jacob‐Wagner MSc, Simon Gagnon PhD, Manon St‐Hilaire MT, Nathalie Lussier MD, Ariane Yechouron MD, David Roy PhD ,Michel Roger MD, PhD Judith Fafard MD

Journal of Medical Virology

First published: 14 April 2021



26. Novel 1,2,3‐Triazole Derivatives as Potential Inhibitors against Covid‐19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies

Mohamed Reda Aouad, Daoud J. O. Khan, Musa A. Said, Nadia S. Al‐Kaff, Nadjet Rezki, Adeeb A. Ali ,Nahla Bouqellah, Mohamed Hagar


First published: 14 April 2021





1. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Meng-Hsuan Lin, Yi-Ping Huang, Chi-Fon Chang, Chun-Hua Hsu in Biomolecular NMR Assignments (2021)



2. Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9

Erika F. Dudás, Rita Puglisi, Sophie Marianne Korn… in Biomolecular NMR Assignments (2021)



3. Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting

Dacre Knight, Katheryne Downes, Bala Munipalli… in SN Comprehensive Clinical Medicine (2021)



4. Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study

Pablo Sieber, Domenica Flury, Sabine Güsewell, Werner C. Albrich… in BMC Infectious Diseases (2021)



5. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19)

Rosemond Qian-Xiu Tan, Wai Tak Victor Li, Wing-Zi Shum… in Systematic Reviews (2021)



6. Clinical Application of Chest Computed Tomography (CT) in Detection and Characterization of Coronavirus (Covid-19) Pneumonia in Adults

Mohamed N. E. Kassem, Doaa T. Masallat in Journal of Digital Imaging (2021)



7. Upper Extremity Arterial Thromboembolism in a Coronavirus Patient. A Case Report

Beverley-Ann Scott, Karan Garg, William Johnson… in SN Comprehensive Clinical Medicine (2021)



8. Temporal relationship between serial RT-PCR results and serial chest CT imaging, and serial CT changes in coronavirus 2019 (COVID-19) pneumonia: a descriptive study of 155 cases in China

Jinfeng Gu, Li Yang, Tao Li, Ye Liu, Jing Zhang, Kejia Ning… in European Radiology (2021)



9. The risk of transmission of the novel coronavirus (SARS-CoV-2) with human heart valve transplantation: evaluation of cardio-vascular tissues from two consecutive heart donors with asymptomatic COVID-19

R. Jashari, M. Van Esbroeck, J. Vanhaebost, I. Micalessi… in Cell and Tissue Banking (2021)



10. Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations

Zhanna Belaya, Olga Golounina, Galina Melnichenko, Natalia Tarbaeva… in Endocrine (2021)



11. Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)

Shobha Upreti, Jyoti Sankar Prusty, Satish Chandra Pandey… in Molecular Diversity (2021)



12. Pseudoviruses for the assessment of coronavirus disinfection by ozone

Ines Zucker, Yaal Lester, Joel Alter, Michal Werbner… in Environmental Chemistry Letters (2021)



13. Experimental tracking and numerical mapping of novel coronavirus micro-droplet deposition through nasal inhalation in the human respiratory system

Hamidreza Mortazavy Beni, Hamed mortazavi… in Biomechanics and Modeling in Mechanobiology (2021)



14. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Yassir A. Almofti, Khoubieb Ali Abd-elrahman, Elsideeq E. M. Eltilib in BMC Immunology (2021)



15. Early Warning Factors of Death in COVID-19 Patients

Min Shang, Jie Wei, Han-dong Zou, Qing-shan Zhou, Yun-ting Zhang… in Current Medical Science (2021)



16. Peptides-based vaccine against SARS-nCoV-2 antigenic fragmented synthetic epitopes recognized by T cell and β-cell initiation of specific antibodies to fight the infection

Zainularifeen Abduljaleel, Faisal A. Al-Allaf, Syed A. Aziz in Bio-Design and Manufacturing (2021)



17. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein

Tianyi Gao, Yingdong Gao, Xiangxiang Liu, Zhenlin Nie, Huilin Sun… in BMC Microbiology (2021)



18. Differences in Immune Responses between Children and Adults with COVID-19

Yin Yuan, Qiu-peng Wang, Dan Sun, Zu-bo Wu, Hua Peng… in Current Medical Science (2021)



19. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples

Daniëlle A. T. Hanssen, Michiel Slaats… in European Journal of Clinical Microbiology … (2021)



20. SARS-CoV-2 infection and thrombotic complications: a narrative review

Iraklis C. Moschonas, Alexandros D. Tselepis in Journal of Thrombosis and Thrombolysis (2021)



21. Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients

Saibin Wang, Yijun Sheng, Junwei Tu, Lanlan Zhang in BMC Pulmonary Medicine (2021)



22. Clinical characteristics and risk factors for mortality in cancer patients with COVID-19

Junnan Liang, Guannan Jin, Tongtong Liu, Jingyuan Wen, Ganxun Li… in Frontiers of Medicine (2021)



23. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2

Francis K. Yoshimoto in The Protein Journal (2021)


24. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids

Ke-Ying Fang, Wen-Chao Cao, Tian-Ao Xie, Jie Lv, Jia-Xin Chen… in Human Genomics (2021)



25. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development

Shima Moradi-kalbolandi, Keyvan Majidzadeh-A… in Probiotics and Antimicrobial Proteins (2021)



26. Effects of SARS-CoV-2 infection on neuroimaging and neurobehavior in neonates

Kai Yan, Fei-Fan Xiao, Yu-Wei Jiang, Tian-Tian Xiao… in World Journal of Pediatrics (2021)



27. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study

Zhi Ao, Yan Li, Jiawei Wei, Jinyue Jiang… in Clinical and Experimental Medicine (2021)



28. Diagnosis of COVID-19 using CT scan images and deep learning techniques

Vruddhi Shah, Rinkal Keniya, Akanksha Shridharani, Manav Punjabi… in Emergency Radiology (2021)



29. Detection of SARS-CoV-2 in fecal samples with different pretreatment methods and PCR kits

Ranran Cao, Lirong Bao, Ming Pan, Cheng Zhang, Hongyu Liao, Li Liu… in BMC Microbiology (2021)



30. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19

Xiaowei Xie, Xuelian Cheng, Gaoxiang Wang, Biao Zhang… in Science China Life Sciences (2021)



31. Angiotensin-Converting Enzyme Type 2 as a Molecular Mediator for Infection of Cells with SARS-CoV and SARS-CoV-2 Viruses

A. O. Shpakov in Neuroscience and Behavioral Physiology (2021)



32. Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment

Arefeh Basiri, Fatemeh Mansouri, Arezo Azari… in Stem Cell Reviews and Reports (2021)



33. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

Changzhong Jin, Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou… in BMC Infectious Diseases (2021)



34. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group

Désirée Larenas-Linnemann, Jorge Luna-Pech… in Current Allergy and Asthma Reports (2021)



35. Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors

Ahmad Sattari, Ali Ramazani… in Journal of the Iranian Chemical Society (2021)



36. Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study

Anish Nag, Ritesh Banerjee, Rajshree Roy Chowdhury… in VirusDisease (2021)



37. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

Dongsheng Wang, Binqing Fu, Zhen Peng, Dongliang Yang… in Frontiers of Medicine (2021)



38. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients

Jing Zhang, Xin Rao, Yiming Li, Yuan Zhu, Fang Liu… in Annals of Intensive Care (2021)



39. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes

Yuki Iwasaki, Takashi Abe, Toshimichi Ikemura in BMC Microbiology (2021)



40. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery

Sk. Abdul Amin, Kalyan Ghosh, Samayaditya Singh, Insaf Ahmed Qureshi… in Molecular Diversity (2021)



41. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study

Arturo Artero MD PhD, Manuel Madrazo MD PhD… in Journal of General Internal Medicine (2021)



42. Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics

Mohammad Uzzal Hossain… in Journal of Genetic Engineering and Biotech… (2021)



43. The severity and atypical presentations of COVID-19 infection in pediatrics

Nagwan Y. Saleh, Hesham M. Aboelghar, Sherif S. Salem, Reda A. Ibrahem… in BMC Pediatrics (2021)



44. Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors

Ramachandran Vijayan, Samudrala Gourinath in Journal of Proteins and Proteomics (2021)



45. A Novel Prediction Model for Long-Term SARS-CoV-2 RNA Shedding in Non-Severe Adult Hospitalized Patients with COVID-19: A Retrospective Cohort Study

Chen Lu Huang, Ling Fei, WeiXia Li, Wei Xu, Xu Dong Xie… in Infectious Diseases and Therapy (2021)



46. Embedded System Prototype to Fight Covid-19 Pandemic Contamination with Less Cost

H. E. Adardour, M. Hadjila, S. M. H. Irid… in Wireless Personal Communications (2021)



47. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh… in BMC Infectious Diseases (2021)



48. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses

Jennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish… in Journal of Clinical Immunology (2021)



49. Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2

Léna Petit, Léa Vernès, Jean-Paul Cadoret in Journal of Applied Phycology (2021)



50. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

José David Torres-Peña, Luis M. Pérez-Belmonte, Francisco Fuentes-Jiménez… in Drugs (2021)






1. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

Hoffmann HH, Sánchez-Rivera FJ, Schneider WM, Luna JM, Soto-Feliciano YM, Ashbrook AW, Le Pen J, Leal AA, Ricardo-Lax I, Michailidis E, Hao Y, Stenzel AF, Peace A, Zuber J, Allis CD, Lowe SW, MacDonald MR, Poirier JT, Rice CM.

Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5



2. Application of plasmapheresis for Covid-19 patients

Turgutkaya A, Yavaşoğlu İ, Bolaman Z.

Ther Apher Dial. 2021 Apr;25(2):248-249.


3. Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?

Rawat P, Jemimah S, Ponnuswamy PK, Gromiha MM.

Proteins. 2021 Apr;89(4):389-398.



4. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis

Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A.

Arch Gerontol Geriatr. 2021 Mar-Apr;93:104299.



5. Immunological characteristics govern the transition of COVID-19 to endemicity.

Lavine JS, Bjornstad ON, Antia R.

Science. 2021 Feb 12;371(6530):741-745.



6. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system

Zhu Q, Zhang Y, Wang L, Yao X, Wu D, Cheng J, Pan X, Liu H, Yan Z, Gao L.

Antiviral Res. 2021 Mar;187:105015.



7. The SARS-CoV-2 RNA-protein interactome in infected human cells.

Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, Melanson R, Werner S, Wei Y, Zimmer M, Ade J, Kirschner L, Zielinski S, Dölken L, Lander ES, Caliskan N, Fischer U, Vogel J, Carr SA, Bodem J, Munschauer M.

Nat Microbiol. 2021 Mar;6(3):339-353.



8. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.

Ji D, Juhas M, Tsang CM, Kwok CK, Li Y, Zhang Y.

Brief Bioinform. 2021 Mar 22;22(2):1150-1160.



9. SARS-Cov-2 ORF3a: Mutability and function.

Bianchi M, Borsetti A, Ciccozzi M, Pascarella S.

Int J Biol Macromol. 2021 Feb 15;170:820-826.



10. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.

Miao G, Zhao H, Li Y, Ji M, Chen Y, Shi Y, Bi Y, Wang P, Zhang H.

Dev Cell. 2021 Feb 22;56(4):427-442.e5



11. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?

Garvey LH, Nasser S.

Br J Anaesth. 2021 Mar;126(3):e106-e108

Nguồn: Cục Thông tin KH&CN quốc gia

Lượt xem: 931

Tìm theo ngày :

Đánh giá

(Di chuột vào ngôi sao để chọn điểm)